APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Enzyme Replacement Therapy

Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme.

Selected research

Industry Growth & Trends

Global Enzyme Replacement Therapy Industry Growth and Trends Forecast to 2032

Report ID 173905660121 December 2025105 pages

Choose your research edition.

Industry ResearchEnzyme Replacement Therapy Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Enzyme Replacement Therapy Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Enzyme Replacement Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enzyme Replacement Therapy Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Enzyme Replacement Therapy Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme.

Global Enzyme Replacement Therapy key players include Johnson & Johnson, Allergan, AbbVie, etc. Global top three manufacturers hold a share about 95%.

North America is the largest market, with a share about 70%, followed by Europe, and Asia-Pacific, both have a share over 25 percent.

Read the full market overview

In terms of product, Oral Agents is the largest segment, with a share nearly 95%. And in terms of application, the largest application is MPS Disease, followed by Gastrointestinal Diseases, Gaucher Disease, Fabry Disease, etc.

Report Scope

This report provides a structured, data-driven view of the global Enzyme Replacement Therapy market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Enzyme Replacement Therapy market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Enzyme Replacement Therapy market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Enzyme Replacement Therapy.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Enzyme Replacement Therapy market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Enzyme Replacement Therapy Market by Company

Sanofi

Takeda

BioMarin

AbbVie

Alexion

Allergan

Horizon Pharma

Johnson & Johnson

Actelion

Recordati Rare Diseases

Pfizer

Digestive Care

Leadiant Biosciences

Enzyme Replacement Therapy Segment by Type

Injectable Agents

Oral Agents

Enzyme Replacement Therapy Segment by Application

Gaucher Disease

Fabry Disease

MPS Disease

Gastrointestinal Disease

Others

Enzyme Replacement Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzyme Replacement Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enzyme Replacement Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzyme Replacement Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Enzyme Replacement Therapy manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Enzyme Replacement Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injectable Agents Table 2. Major Company of Oral Agents Table 3. Global Enzyme Replacement Therapy Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Enzyme Replacement Therapy Sales by Type (2021-2026) & (K Units) Table 5. Global Enzyme Replacement Therapy Sales Market Share in Volume by Type (2021-2026) Table 6. Global Enzyme Replacement Therapy Sales by Type (2021-2026) & (US$ Million) Table 7. Global Enzyme Replacement Therapy Sales Market Share in Value by Type (2021-2026) Table 8. Global Enzyme Replacement Therapy Price by Type (2021-2026) & (USD/Unit) Table 9. Global Enzyme Replacement Therapy Sales by Type (2027-2032) & (K Units) Table 10. Global Enzyme Replacement Therapy Sales Market Share in Volume by Type (2027-2032) Table 11. Global Enzyme Replacement Therapy Sales by Type (2027-2032) & (US$ Million) Table 12. Global Enzyme Replacement Therapy Sales Market Share in Value by Type (2027-2032) Table 13. Global Enzyme Replacement Therapy Price by Type (2027-2032) & (USD/Unit) Table 14. North America Enzyme Replacement Therapy Sales by Type (2021-2026) & (K Units) Table 15. North America Enzyme Replacement Therapy Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Enzyme Replacement Therapy Sales by Type (2021-2026) & (K Units) Table 17. Europe Enzyme Replacement Therapy Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Enzyme Replacement Therapy Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Enzyme Replacement Therapy Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Enzyme Replacement Therapy Sales by Type (2021-2026) & (K Units) Table 21. Latin America Enzyme Replacement Therapy Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Enzyme Replacement Therapy Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Enzyme Replacement Therapy Sales by Type (2021-2026) & (US$ Million) Table 24. Enzyme Replacement Therapy Industry Trends Table 25. Enzyme Replacement Therapy Industry Drivers Table 26. Enzyme Replacement Therapy Industry Opportunities and Challenges Table 27. Enzyme Replacement Therapy Industry Restraints Table 28. Global Enzyme Replacement Therapy Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Enzyme Replacement Therapy Revenue Market Share by Company (2021-2026) Table 30. Global Enzyme Replacement Therapy Sales by Company (2021-2026) & (K Units) Table 31. Global Enzyme Replacement Therapy Sales Share by Company (2021-2026) Table 32. Global Enzyme Replacement Therapy Market Price by Company (2021-2026) & (USD/Unit) Table 33. Global Enzyme Replacement Therapy Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Enzyme Replacement Therapy Major Company Production Sites and Headquarters Table 35. Global Enzyme Replacement Therapy Company, Product Type & Application Table 36. Global Enzyme Replacement Therapy Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Enzyme Replacement Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Enzyme Replacement Therapy Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Enzyme Replacement Therapy Sales by Region (2021-2026) & (K Units) Table 41. Global Enzyme Replacement Therapy Sales Market Share in Volume by Region (2021-2026) Table 42. Global Enzyme Replacement Therapy Sales by Region (2021-2026) & (US$ Million) Table 43. Global Enzyme Replacement Therapy Sales Market Share in Value by Region (2021-2026) Table 44. Global Enzyme Replacement Therapy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 45. Global Enzyme Replacement Therapy Sales by Region (2027-2032) & (K Units) Table 46. Global Enzyme Replacement Therapy Sales Market Share in Volume by Region (2027-2032) Table 47. Global Enzyme Replacement Therapy Sales by Region (2027-2032) & (US$ Million) Table 48. Global Enzyme Replacement Therapy Sales Market Share in Value by Region (2027-2032) Table 49. Global Enzyme Replacement Therapy Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 50. Global Enzyme Replacement Therapy Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Enzyme Replacement Therapy Sales by Application (2021-2026) & (K Units) Table 52. Global Enzyme Replacement Therapy Sales Market Share in Volume by Application (2021-2026) Table 53. Global Enzyme Replacement Therapy Sales by Application (2021-2026) & (US$ Million) Table 54. Global Enzyme Replacement Therapy Sales Market Share in Value by Application (2021-2026) Table 55. Global Enzyme Replacement Therapy Price by Application (2021-2026) & (USD/Unit) Table 56. Global Enzyme Replacement Therapy Sales by Application (2027-2032) & (K Units) Table 57. Global Enzyme Replacement Therapy Sales Market Share in Volume by Application (2027-2032) Table 58. Global Enzyme Replacement Therapy Sales by Application (2027-2032) & (US$ Million) Table 59. Global Enzyme Replacement Therapy Sales Market Share in Value by Application (2027-2032) Table 60. Global Enzyme Replacement Therapy Price by Application (2027-2032) & (USD/Unit) Table 61. North America Enzyme Replacement Therapy Sales by Application (2021-2026) & (K Units) Table 62. North America Enzyme Replacement Therapy Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Enzyme Replacement Therapy Sales by Application (2021-2026) & (K Units) Table 64. Europe Enzyme Replacement Therapy Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Enzyme Replacement Therapy Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Enzyme Replacement Therapy Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Enzyme Replacement Therapy Sales by Application (2021-2026) & (K Units) Table 68. Latin America Enzyme Replacement Therapy Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Enzyme Replacement Therapy Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Enzyme Replacement Therapy Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 74. Sanofi Enzyme Replacement Therapy Product Portfolio Table 75. Sanofi Recent Development Table 76. Takeda Company Information Table 77. Takeda Business Overview Table 78. Takeda Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 79. Takeda Enzyme Replacement Therapy Product Portfolio Table 80. Takeda Recent Development Table 81. BioMarin Company Information Table 82. BioMarin Business Overview Table 83. BioMarin Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 84. BioMarin Enzyme Replacement Therapy Product Portfolio Table 85. BioMarin Recent Development Table 86. AbbVie Company Information Table 87. AbbVie Business Overview Table 88. AbbVie Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 89. AbbVie Enzyme Replacement Therapy Product Portfolio Table 90. AbbVie Recent Development Table 91. Alexion Company Information Table 92. Alexion Business Overview Table 93. Alexion Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Alexion Enzyme Replacement Therapy Product Portfolio Table 95. Alexion Recent Development Table 96. Allergan Company Information Table 97. Allergan Business Overview Table 98. Allergan Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 99. Allergan Enzyme Replacement Therapy Product Portfolio Table 100. Allergan Recent Development Table 101. Horizon Pharma Company Information Table 102. Horizon Pharma Business Overview Table 103. Horizon Pharma Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 104. Horizon Pharma Enzyme Replacement Therapy Product Portfolio Table 105. Horizon Pharma Recent Development Table 106. Johnson & Johnson Company Information Table 107. Johnson & Johnson Business Overview Table 108. Johnson & Johnson Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 109. Johnson & Johnson Enzyme Replacement Therapy Product Portfolio Table 110. Johnson & Johnson Recent Development Table 111. Actelion Company Information Table 112. Actelion Business Overview Table 113. Actelion Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 114. Actelion Enzyme Replacement Therapy Product Portfolio Table 115. Actelion Recent Development Table 116. Recordati Rare Diseases Company Information Table 117. Recordati Rare Diseases Business Overview Table 118. Recordati Rare Diseases Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 119. Recordati Rare Diseases Enzyme Replacement Therapy Product Portfolio Table 120. Recordati Rare Diseases Recent Development Table 121. Pfizer Company Information Table 122. Pfizer Business Overview Table 123. Pfizer Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 124. Pfizer Enzyme Replacement Therapy Product Portfolio Table 125. Pfizer Recent Development Table 126. Digestive Care Company Information Table 127. Digestive Care Business Overview Table 128. Digestive Care Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 129. Digestive Care Enzyme Replacement Therapy Product Portfolio Table 130. Digestive Care Recent Development Table 131. Leadiant Biosciences Company Information Table 132. Leadiant Biosciences Business Overview Table 133. Leadiant Biosciences Enzyme Replacement Therapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 134. Leadiant Biosciences Enzyme Replacement Therapy Product Portfolio Table 135. Leadiant Biosciences Recent Development Table 136. North America Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 137. North America Enzyme Replacement Therapy Sales by Country (2021-2026) & (K Units) Table 138. North America Enzyme Replacement Therapy Sales Market Share by Country (2021-2026) Table 139. North America Enzyme Replacement Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 140. North America Enzyme Replacement Therapy Sales Market Share Forecast by Country (2027-2032) Table 141. North America Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. North America Enzyme Replacement Therapy Market Size by Country (2021-2026) & (US$ Million) Table 143. North America Enzyme Replacement Therapy Market Share by Country (2021-2026) Table 144. North America Enzyme Replacement Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. North America Enzyme Replacement Therapy Market Share Forecast by Country (2027-2032) Table 146. Europe Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 147. Europe Enzyme Replacement Therapy Sales by Country (2021-2026) & (K Units) Table 148. Europe Enzyme Replacement Therapy Sales Market Share by Country (2021-2026) Table 149. Europe Enzyme Replacement Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 150. Europe Enzyme Replacement Therapy Sales Market Share Forecast by Country (2027-2032) Table 151. Europe Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Europe Enzyme Replacement Therapy Market Size by Country (2021-2026) & (US$ Million) Table 153. Europe Enzyme Replacement Therapy Market Share by Country (2021-2026) Table 154. Europe Enzyme Replacement Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Europe Enzyme Replacement Therapy Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Enzyme Replacement Therapy Sales by Country (2021-2026) & (K Units) Table 158. Asia-Pacific Enzyme Replacement Therapy Sales Market Share by Country (2021-2026) Table 159. Asia-Pacific Enzyme Replacement Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 160. Asia-Pacific Enzyme Replacement Therapy Sales Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Enzyme Replacement Therapy Market Size by Country (2021-2026) & (US$ Million) Table 163. Asia-Pacific Enzyme Replacement Therapy Market Share by Country (2021-2026) Table 164. Asia-Pacific Enzyme Replacement Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Asia-Pacific Enzyme Replacement Therapy Market Share Forecast by Country (2027-2032) Table 166. Latin America Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 167. Latin America Enzyme Replacement Therapy Sales by Country (2021-2026) & (K Units) Table 168. Latin America Enzyme Replacement Therapy Sales Market Share by Country (2021-2026) Table 169. Latin America Enzyme Replacement Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 170. Latin America Enzyme Replacement Therapy Sales Market Share Forecast by Country (2027-2032) Table 171. Latin America Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Latin America Enzyme Replacement Therapy Market Size by Country (2021-2026) & (US$ Million) Table 173. Latin America Enzyme Replacement Therapy Market Share by Country (2021-2026) Table 174. Latin America Enzyme Replacement Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Latin America Enzyme Replacement Therapy Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Enzyme Replacement Therapy Sales by Country (2021-2026) & (K Units) Table 178. Middle East and Africa Enzyme Replacement Therapy Sales Market Share by Country (2021-2026) Table 179. Middle East and Africa Enzyme Replacement Therapy Sales Forecast by Country (2027-2032) & (K Units) Table 180. Middle East and Africa Enzyme Replacement Therapy Sales Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Enzyme Replacement Therapy Market Size by Country (2021-2026) & (US$ Million) Table 183. Middle East and Africa Enzyme Replacement Therapy Market Share by Country (2021-2026) Table 184. Middle East and Africa Enzyme Replacement Therapy Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Middle East and Africa Enzyme Replacement Therapy Market Share Forecast by Country (2027-2032) Table 186. Key Raw Materials Table 187. Raw Materials Key Suppliers Table 188. Enzyme Replacement Therapy Distributors List Table 189. Enzyme Replacement Therapy Customers List Table 190. Research Programs/Design for This Report Table 191. Authors List of This Report Table 192. Secondary Sources Table 193. Primary Sources List of Figures Figure 1. Enzyme Replacement Therapy Image Figure 2. Global Enzyme Replacement Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enzyme Replacement Therapy Market Size (2021-2032) & (US$ Million) Figure 4. Global Enzyme Replacement Therapy Sales (2021-2032) & (K Units) Figure 5. Injectable Agents Image Figure 6. Global Injectable Agents Sales YoY Growth (2021-2032) & (K Units) Figure 7. Oral Agents Image Figure 8. Global Oral Agents Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Enzyme Replacement Therapy Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Enzyme Replacement Therapy Market Share by Type 2025 VS 2032 Figure 11. North America Enzyme Replacement Therapy Sales Market Share in Volume by Type in 2025 Figure 12. North America Enzyme Replacement Therapy Sales Market Share in Value by Type in 2025 Figure 13. Europe Enzyme Replacement Therapy Sales Market Share in Volume by Type in 2025 Figure 14. Europe Enzyme Replacement Therapy Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Enzyme Replacement Therapy Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Enzyme Replacement Therapy Sales Market Share in Value by Type in 2025 Figure 17. Latin America Enzyme Replacement Therapy Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Enzyme Replacement Therapy Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Enzyme Replacement Therapy Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Enzyme Replacement Therapy Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Enzyme Replacement Therapy Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Gaucher Disease Image Figure 24. Global Gaucher Disease Sales YoY Growth (2021-2032) & (K Units) Figure 25. Fabry Disease Image Figure 26. Global Fabry Disease Sales YoY Growth (2021-2032) & (K Units) Figure 27. MPS Disease Image Figure 28. Global MPS Disease Sales YoY Growth (2021-2032) & (K Units) Figure 29. Gastrointestinal Disease Image Figure 30. Global Gastrointestinal Disease Sales YoY Growth (2021-2032) & (K Units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 33. Global Enzyme Replacement Therapy Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Enzyme Replacement Therapy Market Share by Application 2025 VS 2032 Figure 35. North America Enzyme Replacement Therapy Sales Market Share in Volume by Application in 2025 Figure 36. North America Enzyme Replacement Therapy Sales Market Share in Value by Application in 2025 Figure 37. Europe Enzyme Replacement Therapy Sales Market Share in Volume by Application in 2025 Figure 38. Europe Enzyme Replacement Therapy Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Enzyme Replacement Therapy Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Enzyme Replacement Therapy Sales Market Share in Value by Application in 2025 Figure 41. Latin America Enzyme Replacement Therapy Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Enzyme Replacement Therapy Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Enzyme Replacement Therapy Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Enzyme Replacement Therapy Sales Market Share in Value by Application in 2025 Figure 45. North America Enzyme Replacement Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. North America Enzyme Replacement Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Enzyme Replacement Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Enzyme Replacement Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Enzyme Replacement Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Europe Enzyme Replacement Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Enzyme Replacement Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Enzyme Replacement Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Enzyme Replacement Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Asia-Pacific Enzyme Replacement Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Enzyme Replacement Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Enzyme Replacement Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Enzyme Replacement Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Latin America Enzyme Replacement Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Enzyme Replacement Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Enzyme Replacement Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Enzyme Replacement Therapy Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Middle East and Africa Enzyme Replacement Therapy Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Enzyme Replacement Therapy Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Enzyme Replacement Therapy Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Enzyme Replacement Therapy Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Enzyme Replacement Therapy Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injectable Agents
  • Oral Agents
Applications
  • Gaucher Disease
  • Fabry Disease
  • MPS Disease
  • Gastrointestinal Disease
  • Others
Companies covered
  • Sanofi
  • Takeda
  • BioMarin
  • AbbVie
  • Alexion
  • Allergan
  • Horizon Pharma
  • Johnson & Johnson
  • Actelion
  • Recordati Rare Diseases
  • Pfizer
  • Digestive Care
  • Leadiant Biosciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Enzyme Replacement Therapy Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Enzyme Replacement Therapy Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Enzyme Replacement Therapy Market by Type
  6. 1.3.1 Injectable Agents
  7. 1.3.2 Oral Agents
  8. 1.4 Global Enzyme Replacement Therapy Market Size by Type
  9. 1.4.1 Global Enzyme Replacement Therapy Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Enzyme Replacement Therapy Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Enzyme Replacement Therapy Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Enzyme Replacement Therapy Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Enzyme Replacement Therapy Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Enzyme Replacement Therapy Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Enzyme Replacement Therapy Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Enzyme Replacement Therapy Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Enzyme Replacement Therapy Industry Trends
  2. 2.2 Enzyme Replacement Therapy Industry Drivers
  3. 2.3 Enzyme Replacement Therapy Industry Opportunities and Challenges
  4. 2.4 Enzyme Replacement Therapy Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Enzyme Replacement Therapy Revenue (2021-2026)
  2. 3.2 Global Top Players by Enzyme Replacement Therapy Sales (2021-2026)
  3. 3.3 Global Top Players by Enzyme Replacement Therapy Price (2021-2026)
  4. 3.4 Global Enzyme Replacement Therapy Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Enzyme Replacement Therapy Major Company Production Sites & Headquarters
  6. 3.6 Global Enzyme Replacement Therapy Company, Product Type & Application
  7. 3.7 Global Enzyme Replacement Therapy Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Enzyme Replacement Therapy Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Enzyme Replacement Therapy Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Enzyme Replacement Therapy Tier 1, Tier 2, and Tier 3
4 Enzyme Replacement Therapy Regional Status and Outlook
  1. 4.1 Global Enzyme Replacement Therapy Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Enzyme Replacement Therapy Historic Market Size by Region
  3. 4.2.1 Global Enzyme Replacement Therapy Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Enzyme Replacement Therapy Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Enzyme Replacement Therapy Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Enzyme Replacement Therapy Forecasted Market Size by Region
  7. 4.3.1 Global Enzyme Replacement Therapy Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Enzyme Replacement Therapy Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Enzyme Replacement Therapy Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Enzyme Replacement Therapy by Application
  1. 5.1 Enzyme Replacement Therapy Market by Application
  2. 5.1.1 Gaucher Disease
  3. 5.1.2 Fabry Disease
  4. 5.1.3 MPS Disease
  5. 5.1.4 Gastrointestinal Disease
  6. 5.1.5 Others
  7. 5.2 Global Enzyme Replacement Therapy Market Size by Application
  8. 5.2.1 Global Enzyme Replacement Therapy Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Enzyme Replacement Therapy Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Enzyme Replacement Therapy Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Enzyme Replacement Therapy Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Enzyme Replacement Therapy Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Enzyme Replacement Therapy Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Enzyme Replacement Therapy Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Enzyme Replacement Therapy Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Enzyme Replacement Therapy Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Takeda
  8. 6.2.1 Takeda Company Information
  9. 6.2.2 Takeda Business Overview
  10. 6.2.3 Takeda Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Enzyme Replacement Therapy Product Portfolio
  12. 6.2.5 Takeda Recent Developments
  13. 6.3 BioMarin
  14. 6.3.1 BioMarin Company Information
  15. 6.3.2 BioMarin Business Overview
  16. 6.3.3 BioMarin Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 BioMarin Enzyme Replacement Therapy Product Portfolio
  18. 6.3.5 BioMarin Recent Developments
  19. 6.4 AbbVie
  20. 6.4.1 AbbVie Company Information
  21. 6.4.2 AbbVie Business Overview
  22. 6.4.3 AbbVie Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 AbbVie Enzyme Replacement Therapy Product Portfolio
  24. 6.4.5 AbbVie Recent Developments
  25. 6.5 Alexion
  26. 6.5.1 Alexion Company Information
  27. 6.5.2 Alexion Business Overview
  28. 6.5.3 Alexion Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Alexion Enzyme Replacement Therapy Product Portfolio
  30. 6.5.5 Alexion Recent Developments
  31. 6.6 Allergan
  32. 6.6.1 Allergan Company Information
  33. 6.6.2 Allergan Business Overview
  34. 6.6.3 Allergan Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Allergan Enzyme Replacement Therapy Product Portfolio
  36. 6.6.5 Allergan Recent Developments
  37. 6.7 Horizon Pharma
  38. 6.7.1 Horizon Pharma Company Information
  39. 6.7.2 Horizon Pharma Business Overview
  40. 6.7.3 Horizon Pharma Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Horizon Pharma Enzyme Replacement Therapy Product Portfolio
  42. 6.7.5 Horizon Pharma Recent Developments
  43. 6.8 Johnson & Johnson
  44. 6.8.1 Johnson & Johnson Company Information
  45. 6.8.2 Johnson & Johnson Business Overview
  46. 6.8.3 Johnson & Johnson Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Johnson & Johnson Enzyme Replacement Therapy Product Portfolio
  48. 6.8.5 Johnson & Johnson Recent Developments
  49. 6.9 Actelion
  50. 6.9.1 Actelion Company Information
  51. 6.9.2 Actelion Business Overview
  52. 6.9.3 Actelion Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Actelion Enzyme Replacement Therapy Product Portfolio
  54. 6.9.5 Actelion Recent Developments
  55. 6.10 Recordati Rare Diseases
  56. 6.10.1 Recordati Rare Diseases Company Information
  57. 6.10.2 Recordati Rare Diseases Business Overview
  58. 6.10.3 Recordati Rare Diseases Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Recordati Rare Diseases Enzyme Replacement Therapy Product Portfolio
  60. 6.10.5 Recordati Rare Diseases Recent Developments
  61. 6.11 Pfizer
  62. 6.11.1 Pfizer Company Information
  63. 6.11.2 Pfizer Business Overview
  64. 6.11.3 Pfizer Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Pfizer Enzyme Replacement Therapy Product Portfolio
  66. 6.11.5 Pfizer Recent Developments
  67. 6.12 Digestive Care
  68. 6.12.1 Digestive Care Company Information
  69. 6.12.2 Digestive Care Business Overview
  70. 6.12.3 Digestive Care Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Digestive Care Enzyme Replacement Therapy Product Portfolio
  72. 6.12.5 Digestive Care Recent Developments
  73. 6.13 Leadiant Biosciences
  74. 6.13.1 Leadiant Biosciences Company Information
  75. 6.13.2 Leadiant Biosciences Business Overview
  76. 6.13.3 Leadiant Biosciences Enzyme Replacement Therapy Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Leadiant Biosciences Enzyme Replacement Therapy Product Portfolio
  78. 6.13.5 Leadiant Biosciences Recent Developments
7 North America by Country
  1. 7.1 North America Enzyme Replacement Therapy Sales by Country
  2. 7.1.1 North America Enzyme Replacement Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Enzyme Replacement Therapy Sales by Country (2021-2026)
  4. 7.1.3 North America Enzyme Replacement Therapy Sales Forecast by Country (2027-2032)
  5. 7.2 North America Enzyme Replacement Therapy Market Size by Country
  6. 7.2.1 North America Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Enzyme Replacement Therapy Market Size by Country (2021-2026)
  8. 7.2.3 North America Enzyme Replacement Therapy Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Enzyme Replacement Therapy Sales by Country
  2. 8.1.1 Europe Enzyme Replacement Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Enzyme Replacement Therapy Sales by Country (2021-2026)
  4. 8.1.3 Europe Enzyme Replacement Therapy Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Enzyme Replacement Therapy Market Size by Country
  6. 8.2.1 Europe Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Enzyme Replacement Therapy Market Size by Country (2021-2026)
  8. 8.2.3 Europe Enzyme Replacement Therapy Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Enzyme Replacement Therapy Sales by Country
  2. 9.1.1 Asia-Pacific Enzyme Replacement Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Enzyme Replacement Therapy Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Enzyme Replacement Therapy Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Enzyme Replacement Therapy Market Size by Country
  6. 9.2.1 Asia-Pacific Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Enzyme Replacement Therapy Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Enzyme Replacement Therapy Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Enzyme Replacement Therapy Sales by Country
  2. 10.1.1 South America Enzyme Replacement Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Enzyme Replacement Therapy Sales by Country (2021-2026)
  4. 10.1.3 South America Enzyme Replacement Therapy Sales Forecast by Country (2027-2032)
  5. 10.2 South America Enzyme Replacement Therapy Market Size by Country
  6. 10.2.1 South America Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Enzyme Replacement Therapy Market Size by Country (2021-2026)
  8. 10.2.3 South America Enzyme Replacement Therapy Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Enzyme Replacement Therapy Sales by Country
  2. 11.1.1 Middle East and Africa Enzyme Replacement Therapy Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Enzyme Replacement Therapy Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Enzyme Replacement Therapy Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Enzyme Replacement Therapy Market Size by Country
  6. 11.2.1 Middle East and Africa Enzyme Replacement Therapy Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Enzyme Replacement Therapy Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Enzyme Replacement Therapy Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Enzyme Replacement Therapy Value Chain Analysis
  2. 12.1.1 Enzyme Replacement Therapy Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Enzyme Replacement Therapy Production Mode & Process
  7. 12.2 Enzyme Replacement Therapy Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Enzyme Replacement Therapy Distributors
  10. 12.2.3 Enzyme Replacement Therapy Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst